Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023
“The hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4% during the forecast period.”
The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. Technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, and government focus on critical care infrastructure & services are expected to drive the growth of the hemodynamic monitoring systems market. However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market to a certain extent.
“By product, the monitors segment is expected to grow at the highest rate during the forecast period.”
Based on product, the global hemodynamic monitoring systems market is segmented into two broad categories—monitors and disposables. The monitors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of CVDs; technological advancements in monitoring systems; increasing funding by government authorities for improving patient-centered care, safety, and efficiency; and the ability of hemodynamic monitors to improve cath lab efficiency.
“By type, the noninvasive systems segment is expected to grow at the highest rate during the forecast period (2018–2023).”
On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive systems. The noninvasive hemodynamic monitoring systems segment is expected to grow at the highest CAGR during the forecast owing to the benefits it offers such as reduced staffing costs, treatment expenses, and hospital stay. Furthermore, the rising incidence of respiratory disorders; fewer complications of noninvasive hemodynamic monitoring compared to invasive methods, enhanced portability & precision, and ease of use are additional factors driving the growth of this market segment.
“By end user, the clinics and ambulatory care centers segment is expected to grow at the highest rate during the forecast period.”
On the basis of end user, the global hemodynamic monitoring systems market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. The clinics and ACCs segment is expected to register the highest CAGR during the forecast period due to the growing number of ambulatory care centers globally, improving reimbursements for ACCs, growing number of patients visiting clinics & ACCs, and increasing number of initiatives by governments.
“The Asia Pacific hemodynamic monitoring systems market is expected to grow at the highest CAGR during the forecast period.”
Asia Pacific is expected to witness the highest growth from 2018 to 2023. This high growth rate is attributed to Japan’s growing healthcare industry; extensive government reimbursement coverage for critical cardiac procedures; improving healthcare infrastructure in India and China; high diabetes prevalence in Vietnam, Singapore, Malaysia, China, and India; and government initiatives in Australia and Singapore.
Break of primary participants was as mentioned below:
Research Coverage:
The report analyzes the hemodynamic monitoring systems market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
This report provides insights into the following pointers:
The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. Technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, and government focus on critical care infrastructure & services are expected to drive the growth of the hemodynamic monitoring systems market. However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market to a certain extent.
“By product, the monitors segment is expected to grow at the highest rate during the forecast period.”
Based on product, the global hemodynamic monitoring systems market is segmented into two broad categories—monitors and disposables. The monitors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of CVDs; technological advancements in monitoring systems; increasing funding by government authorities for improving patient-centered care, safety, and efficiency; and the ability of hemodynamic monitors to improve cath lab efficiency.
“By type, the noninvasive systems segment is expected to grow at the highest rate during the forecast period (2018–2023).”
On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive systems. The noninvasive hemodynamic monitoring systems segment is expected to grow at the highest CAGR during the forecast owing to the benefits it offers such as reduced staffing costs, treatment expenses, and hospital stay. Furthermore, the rising incidence of respiratory disorders; fewer complications of noninvasive hemodynamic monitoring compared to invasive methods, enhanced portability & precision, and ease of use are additional factors driving the growth of this market segment.
“By end user, the clinics and ambulatory care centers segment is expected to grow at the highest rate during the forecast period.”
On the basis of end user, the global hemodynamic monitoring systems market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. The clinics and ACCs segment is expected to register the highest CAGR during the forecast period due to the growing number of ambulatory care centers globally, improving reimbursements for ACCs, growing number of patients visiting clinics & ACCs, and increasing number of initiatives by governments.
“The Asia Pacific hemodynamic monitoring systems market is expected to grow at the highest CAGR during the forecast period.”
Asia Pacific is expected to witness the highest growth from 2018 to 2023. This high growth rate is attributed to Japan’s growing healthcare industry; extensive government reimbursement coverage for critical cardiac procedures; improving healthcare infrastructure in India and China; high diabetes prevalence in Vietnam, Singapore, Malaysia, China, and India; and government initiatives in Australia and Singapore.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–55%, Tier 2–25% and Tier 3–20%
- By Designation – C-level–43%, Director Level–32%, Others–25%
- By Region – Europe–38%, North America–23%, Asia Pacific–29%, RoW–10%
Research Coverage:
The report analyzes the hemodynamic monitoring systems market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the hemodynamic monitoring systems market. The report analyzes the market based on product, type, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the hemodynamic monitoring systems market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring systems across regions
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.3.2 MARKETS COVERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET DATA VALIDATION AND TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEMODYNAMIC MONITORING SYSTEMS MARKET OVERVIEW
4.2 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY AND END USER
4.3 GEOGRAPHIC SNAPSHOT: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET
4.4 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE (2018 VS. 2023)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in hemodynamic monitoring systems
5.2.1.2 Microelectromechanical Systems (MEMS)
5.2.1.3 Hypotension Prediction Index (HPI) software
5.2.1.4 Increasing research into hemodynamic monitoring systems
5.2.1.5 Influx of VC funding
5.2.1.6 Rising prevalence of cardiovascular diseases and diabetes
5.2.1.7 Rising geriatric population and growing number of surgeries
5.2.1.8 Awareness initiatives by industry players
5.2.1.9 Government focus on critical care infrastructure and services
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with invasive hemodynamic monitoring
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings
5.2.4 CHALLENGES
5.2.4.1 Increasing pricing pressure on market players
5.2.4.2 Limited patient awareness related to disease diagnosis
5.2.4.3 Dearth of skilled professionals
6 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DISPOSABLES
6.3 MONITORS
7 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 INVASIVE HEMODYNAMIC MONITORING SYSTEMS
7.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS
7.4 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS
8 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 CLINICS AND AMBULATORY CARE CENTERS
8.4 HOME CARE SETTINGS
9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ROE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 ROAPAC
9.5 ROW
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS
10.2.1 EDWARDS LIFESCIENCES CORPORATION
10.2.2 PULSION MEDICAL SYSTEMS SE
10.2.3 LIDCO GROUP PLC
10.3 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS, BY REGION
10.4 COMPETITIVE SCENARIO
11 COMPANY PROFILES
(Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships)*
11.1 EDWARDS LIFESCIENCES CORPORATION
11.2 PULSION MEDICAL SYSTEMS SE (PART OF THE MAQUET GETINGE GROUP)
11.3 LIDCO GROUP
11.4 DELTEX MEDICAL GROUP PLC
11.5 ICU MEDICAL
11.6 CNSYSTEMS MEDIZINTECHNIK GMBH
11.7 CARETAKER MEDICAL
11.8 OSYPKA MEDICAL GMBH
11.9 CHEETAH MEDICAL
11.10 USCOM LIMITED
11.11 NI MEDICAL
*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE: HEMODYNAMIC MONITORING SYSTEMS MARKET
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.3.2 MARKETS COVERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET DATA VALIDATION AND TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEMODYNAMIC MONITORING SYSTEMS MARKET OVERVIEW
4.2 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY AND END USER
4.3 GEOGRAPHIC SNAPSHOT: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET
4.4 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE (2018 VS. 2023)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in hemodynamic monitoring systems
5.2.1.2 Microelectromechanical Systems (MEMS)
5.2.1.3 Hypotension Prediction Index (HPI) software
5.2.1.4 Increasing research into hemodynamic monitoring systems
5.2.1.5 Influx of VC funding
5.2.1.6 Rising prevalence of cardiovascular diseases and diabetes
5.2.1.7 Rising geriatric population and growing number of surgeries
5.2.1.8 Awareness initiatives by industry players
5.2.1.9 Government focus on critical care infrastructure and services
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with invasive hemodynamic monitoring
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Growing demand for patient monitoring devices in non-hospital settings
5.2.4 CHALLENGES
5.2.4.1 Increasing pricing pressure on market players
5.2.4.2 Limited patient awareness related to disease diagnosis
5.2.4.3 Dearth of skilled professionals
6 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DISPOSABLES
6.3 MONITORS
7 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 INVASIVE HEMODYNAMIC MONITORING SYSTEMS
7.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS
7.4 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS
8 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 CLINICS AND AMBULATORY CARE CENTERS
8.4 HOME CARE SETTINGS
9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ROE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 ROAPAC
9.5 ROW
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS
10.2.1 EDWARDS LIFESCIENCES CORPORATION
10.2.2 PULSION MEDICAL SYSTEMS SE
10.2.3 LIDCO GROUP PLC
10.3 HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE ANALYSIS, BY REGION
10.4 COMPETITIVE SCENARIO
11 COMPANY PROFILES
(Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships)*
11.1 EDWARDS LIFESCIENCES CORPORATION
11.2 PULSION MEDICAL SYSTEMS SE (PART OF THE MAQUET GETINGE GROUP)
11.3 LIDCO GROUP
11.4 DELTEX MEDICAL GROUP PLC
11.5 ICU MEDICAL
11.6 CNSYSTEMS MEDIZINTECHNIK GMBH
11.7 CARETAKER MEDICAL
11.8 OSYPKA MEDICAL GMBH
11.9 CHEETAH MEDICAL
11.10 USCOM LIMITED
11.11 NI MEDICAL
*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE: HEMODYNAMIC MONITORING SYSTEMS MARKET
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES
Table 1 INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE HEMODYNAMIC MONITORING SYSTEMS SEGMENT
Table 2 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20–79 YEARS), 2015 VS. 2040
Table 3 POPULATION AGED 60 YEARS AND OVER, BY REGION (IN MILLION)
Table 4 AWARENESS INITIATIVES IN 2017–2018
Table 5 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 6 TYPES OF DISPOSABLES USED IN HEMODYNAMIC MONITORING
Table 7 HEMODYNAMIC MONITORING DISPOSABLES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 8 NORTH AMERICA: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 EUROPE: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 10 ASIA PACIFIC: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 TYPES OF HEMODYNAMIC MONITORS
Table 12 HEMODYNAMIC MONITORS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 13 NORTH AMERICA: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 14 EUROPE: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 ASIA PACIFIC: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 16 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 17 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 18 NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 19 EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 20 ASIA PACIFIC: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 22 NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 24 ASIA PACIFIC: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 26 NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 ASIA PACIFIC: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 30 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD MILLION)
Table 31 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 32 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 36 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 37 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 38 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 40 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 41 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 42 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 43 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 44 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 45 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 46 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 47 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 48 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 49 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 50 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 51 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 52 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 53 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 54 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 55 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 56 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 57 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 58 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 59 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 60 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 61 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 64 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 66 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 67 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 69 PROMINENT RESEARCH PROJECTS FOCUSING ON HEMODYNAMIC MONITORING
Table 70 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 71 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 72 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 74 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 75 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 77 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 78 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 79 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 80 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 81 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 83 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 84 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 86 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 87 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 88 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 89 PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2015-2018
Table 90 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
Table 91 OTHER DEVELOPMENTS
Table 1 INDICATIVE LIST OF COMPANIES THAT RECEIVED VENTURE CAPITALIST FUNDING FOR THE HEMODYNAMIC MONITORING SYSTEMS SEGMENT
Table 2 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20–79 YEARS), 2015 VS. 2040
Table 3 POPULATION AGED 60 YEARS AND OVER, BY REGION (IN MILLION)
Table 4 AWARENESS INITIATIVES IN 2017–2018
Table 5 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 6 TYPES OF DISPOSABLES USED IN HEMODYNAMIC MONITORING
Table 7 HEMODYNAMIC MONITORING DISPOSABLES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 8 NORTH AMERICA: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 EUROPE: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 10 ASIA PACIFIC: HEMODYNAMIC MONITORING MARKET FOR DISPOSABLES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 TYPES OF HEMODYNAMIC MONITORS
Table 12 HEMODYNAMIC MONITORS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 13 NORTH AMERICA: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 14 EUROPE: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 ASIA PACIFIC: HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 16 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 17 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 18 NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 19 EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 20 ASIA PACIFIC: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 22 NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 24 ASIA PACIFIC: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 26 NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 ASIA PACIFIC: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 30 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD MILLION)
Table 31 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 32 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 36 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 37 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR CLINICS AND AMBULATORY CARE CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 38 HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 40 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 41 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 42 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 43 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 44 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 45 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 46 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 47 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 48 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 49 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 50 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 51 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 52 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 53 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 54 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 55 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 56 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 57 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 58 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 59 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 60 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 61 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 64 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 65 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 66 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 67 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 69 PROMINENT RESEARCH PROJECTS FOCUSING ON HEMODYNAMIC MONITORING
Table 70 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 71 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 72 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 74 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 75 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 76 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 77 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 78 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 79 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 80 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 81 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 83 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 84 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 85 ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 86 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 87 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 88 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 89 PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2015-2018
Table 90 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
Table 91 OTHER DEVELOPMENTS
LIST OF FIGURES
Figure 1 HEMODYNAMIC MONITORING SYSTEMS MARKET SEGMENTATION
Figure 2 HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 6 RESEARCH DESIGN
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 MONITORS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS 2023
Figure 10 HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018
Figure 11 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
Figure 12 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING SYTEMS IS THE KEY FACTOR DRIVING THE GROWTH OF THE MARKET
Figure 13 HOSPITALS SEGMENT TO DOMINATE THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018
Figure 14 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 15 INVASIVE SYSTEMS SEGMENT TO COMMAND THE LARGEST MARKET SHARE BY 2023
Figure 16 PERCENTAGE CHANGE IN POPULATION AGED 60 YEARS AND OVER, BY REGION (2000–2030)
Figure 17 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 18 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS. 2023
Figure 19 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 20 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2018 VS. 2023
Figure 21 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 22 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 23 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 24 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 25 KEY DEVELOPMENTS IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET BETWEEN 2015 AND 2018
Figure 26 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 27 NORTH AMERICA: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 28 EUROPE: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 29 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 30 ROW: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 31 GEOGRAPHIC PRESENCE OF KEY PLAYERS
Figure 32 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2017)
Figure 33 PULSION MEDICAL SYSTEMS SE: COMPANY SNAPSHOT (2017)
Figure 34 LIDCO GROUP: COMPANY SNAPSHOT (2017)
Figure 35 DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT (2017)
Figure 36 ICU MEDICAL: COMPANY SNAPSHOT (2017)
Figure 37 USCOM: COMPANY SNAPSHOT (2017)
Figure 1 HEMODYNAMIC MONITORING SYSTEMS MARKET SEGMENTATION
Figure 2 HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 6 RESEARCH DESIGN
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 MONITORS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS 2023
Figure 10 HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018
Figure 11 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
Figure 12 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING SYTEMS IS THE KEY FACTOR DRIVING THE GROWTH OF THE MARKET
Figure 13 HOSPITALS SEGMENT TO DOMINATE THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2018
Figure 14 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 15 INVASIVE SYSTEMS SEGMENT TO COMMAND THE LARGEST MARKET SHARE BY 2023
Figure 16 PERCENTAGE CHANGE IN POPULATION AGED 60 YEARS AND OVER, BY REGION (2000–2030)
Figure 17 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 18 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2018 VS. 2023
Figure 19 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 20 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2018 VS. 2023
Figure 21 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 22 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 23 ASIA PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 24 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
Figure 25 KEY DEVELOPMENTS IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET BETWEEN 2015 AND 2018
Figure 26 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 27 NORTH AMERICA: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 28 EUROPE: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 29 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 30 ROW: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
Figure 31 GEOGRAPHIC PRESENCE OF KEY PLAYERS
Figure 32 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2017)
Figure 33 PULSION MEDICAL SYSTEMS SE: COMPANY SNAPSHOT (2017)
Figure 34 LIDCO GROUP: COMPANY SNAPSHOT (2017)
Figure 35 DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT (2017)
Figure 36 ICU MEDICAL: COMPANY SNAPSHOT (2017)
Figure 37 USCOM: COMPANY SNAPSHOT (2017)
